Kim, B., Yoon, K., Byun, H., Seo, S. H., Lee, S., & Rho, S. B. (2014). The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways. Impact Journals LLC.

Kim, Boh-Ram, Kyungsil Yoon, Hyun-Jung Byun, Seung Hee Seo, Seung-Hoon Lee, und Seung Bae Rho. The Anti-tumor Activator SMEK1 and Paclitaxel Additively Decrease Expression of HIF-1α and VEGF Via MTORC1-S6K/4E-BP-dependent Signaling Pathways. Impact Journals LLC, 2014.

Kim, Boh-Ram, et al. The Anti-tumor Activator SMEK1 and Paclitaxel Additively Decrease Expression of HIF-1α and VEGF Via MTORC1-S6K/4E-BP-dependent Signaling Pathways. Impact Journals LLC, 2014.